Walgreens Boots Alliance is the global pharmacy-led, health and wellbeing enterprise. Its purpose is to help people across the world lead healthier and happier lives. The Company has unmatched supply chain and procurement expertise, offering customers innovative solutions and optimal efficiencies. Also Walgreens Boots Alliance has a portfolio of retail and business brands, including Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as increasingly global health and beauty product brands, such as No7, Botanics, Liz Earle and Soap & Glory.
The creation of Walgreens Boots Alliance provides an opportunity to further accelerate the development of a fully integrated, global platform for the future to provide innovative ways to address health and wellness challenges. The Company is well positioned to expand customer offerings in existing markets and become the health and wellbeing partner of choice in emerging markets.
Company Growth (employees)
Type
Public
HQ
Deerfield, US
Founded
2014
Size (employees)
240,000 (est)-33%
Website
walgreensbootsalliance.comWalgreens Boots Alliance was founded in 2014 and is headquartered in Deerfield, US
Walgreens Boots Alliance Office Locations
Walgreens Boots Alliance has an office in Deerfield
Deerfield, US (HQ)
108 Wilmot Rd
Walgreens Boots Alliance Data and Metrics
Walgreens Boots Alliance Financial Metrics
Walgreens Boots Alliance's revenue was reported to be $117.4 b in FY, 2016 which is a 13% increase from the previous period.
$, USD
Revenue (FY, 2016) | 117.4 b |
Revenue growth (FY, 2015 - FY, 2016), % | 13% |
Gross profit (FY, 2016) | 29.9 b |
Gross profit margin (FY, 2016), % | 25% |
Net income (FY, 2016) | 4.2 b |
EBIT (FY, 2016) | 6 b |
Market capitalization (22-Jun-2017) | 82.6 b |
Closing share price (22-Jun-2017) | 78.1 |
Cash (31-Dec-2016) | 9.8 b |
EV | 91.8 b |
Walgreens Boots Alliance's current market capitalization is $82.6 b.
- Source: SEC Filings
| $, USD | FY, 2015 | FY, 2016 |
|---|---|---|
Revenue | 103.4 b | 117.4 b |
Revenue growth, % | 13% | |
Cost of goods sold | 76.5 b | 87.5 b |
Gross profit | 26.9 b | 29.9 b |
Gross profit Margin, % | 26% | 25% |
EBIT | 4.7 b | 6 b |
EBIT margin, % | 5% | 5% |
Pre tax profit | 5.3 b | 5.1 b |
Net Income | 4.3 b | 4.2 b |
- Source: SEC Filings
| $, USD | FY, 2015 | FY, 2016 |
|---|---|---|
Cash | 3 b | 9.8 b |
Accounts Receivable | 6.8 b | 6.3 b |
Inventories | 8.7 b | 9 b |
Current Assets | 19.7 b | 25.9 b |
PP&E | 15.1 b | 14.3 b |
Goodwill | 16.4 b | 15.5 b |
Total Assets | 68.8 b | 72.7 b |
Accounts Payable | 10.1 b | 11 b |
Total Debt | 14.4 b | 19 b |
Current Liabilities | 16.6 b | 17 b |
Non-Current Liabilities | 20.9 b | 25.4 b |
Total Liabilities | 37.5 b | 42.4 b |
Additional Paid-in Capital | 10 b | 10.1 b |
Retained Earnings | 25.1 b | 27.7 b |
Total Equity | 31.3 b | 30.3 b |
EPS | 4.1 | 3.9 |
Debt to Equity Ratio | 0.5 x | 0.6 x |
Debt to Assets Ratio | 0.2 x | 0.3 x |
Financial Leverage | 2.2 x | 2.4 x |
| $, USD | FY, 2015 | FY, 2016 |
|---|---|---|
Net Income | 4.3 b | 4.2 b |
Depreciation and Amortization | 1.7 b | 1.7 b |
Accounts Receivable | (338 m) | 115 m |
Inventories | 719 m | (644 m) |
Accounts Payable | 268 m | 1.6 b |
Cash From Operating Activities | 5.7 b | 7.8 b |
Purchases of PP&E | (1.3 b) | (1.3 b) |
Cash From Investing Activities | (4.3 b) | (3.5 b) |
Short-term Borrowings | (226 m) | |
Long-term Borrowings | (10.5 b) | (791 m) |
Dividends Paid | (1.4 b) | (1.6 b) |
Cash From Financing Activities | (915 m) | 2.6 b |
Income Taxes Paid | (335 m) | 202 m |
| $, USD | Y, 2016 |
|---|---|
P/E Ratio | 20.3 |
EV/EBIT | 15.3 x |
EV/CFO | 11.7 x |
Revenue/Employee | 387.9 k |
Debt/Equity | 0.6 x |
Debt/Assets | 0.3 x |
Financial Leverage | 2.4 x |
Walgreens Boots Alliance Operating Metrics
Walgreens Boots Alliance's Stores was reported to be 13.2 k in FY, 2016. Walgreens Boots Alliance's Enterprise Customers was reported to be 230 k in FY, 2016. Walgreens Boots Alliance's Prescriptions Filled was reported to be 928.5 m in FY, 2016. Walgreens Boots Alliance's Distribution Centers was reported to be 390 in FY, 2016
- Source: SEC Filings
